FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome

A quantitative defect of Tregs, suggestive of decreased peripheral tolerance, could be a potential hallmark of ACS disease. Targeting FOXP3 i l demethylation might elevate the inhibitory activity of Tregs in ACS.